Anti-sporozoite monoclonal antibody for malaria prevention: secondary efficacy outcome of a phase 2 randomized trial
用于疟疾预防的抗子孢子单克隆抗体:一项 II 期随机试验的次要疗效终点
期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-025-03739-y
Skinner, Jeff; Kayentao, Kassoum; Ongoiba, Aissata; Healy, Sara A; Hu, Zonghui; Preston, Anne C; Niangaly, Amadou; Schwabl, Philipp; Cisse, Hamidou; Doumbo, Safiatou; Doumtabe, Didier; Traore, Abdrahamane; Li, Shanping; Peterson, Mary E; Seilie, Annette M; Chavtur, Chris; Staubus, Weston; Chang, Ming; Kelley, Katrina; Traore, Hamadi; Djiguiba, Adama; Keita, Mamadou; Ouattara, Adama; Doucoure, M'Bouye; Keita, Mohamed; Diarra, Djelika; Sylla, Mamadou; Diakite, Dramane; Konate, Mamadou; Traore, Siriman; Zéguimé, Amatigué; Dolo, Amagana; Neafsey, Daniel E; Murphy, Sean C; Traore, Boubacar; Seder, Robert A; Crompton, Peter D